Stay updated on Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the Record History and the previous revision v3.5.3 was removed, signifying an editorial update to the page's metadata.
    Difference
    0.1%
    Check dated 2026-05-15T09:32:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s displayed software/content revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change rather than any study data update.
    Difference
    0.1%
    Check dated 2026-04-24T04:24:09.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added revision: v3.5.2 and removed revision: v3.5.0 from the record history.
    Difference
    0.1%
    Check dated 2026-04-16T21:32:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the history and removed revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:16:42.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-11T18:04:00.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    A new site revision label 'Revision: v3.4.2' was added, and the prior government funding notice and the 'Revision: v3.4.1' label were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T09:27:52.000Z thumbnail image

Stay in the know with updates to Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial page.